According to filings with the U.S. Securities and Exchange Commission, WellTheory Technologies is raising up to $19,049,978.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About WellTheory Technologies
Autoimmune conditions are rising faster than any other disease, now affecting over 50 million Americans. Yet they remain misunderstood, underdiagnosed, and overlooked. WellTheory is here to change that with a new kind of care thats personalized, rooted in science, powered by AI, and delivered with compassion. We help people reduce symptoms, feel better, and live fuller lives while helping employers and payors reduce their spend.

To learn more about WellTheory Technologies, visit https://www.welltheory.com/
WellTheory Technologies Linkedin Page: https://www.linkedin.com/company/welltheory/

Contact:
Ellen Rudolph, Chief Executive Officer
415-676-9315
https://www.linkedin.com/in/ellenrudolph/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.